PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast

References

• [SRBS] A statistics Report from the British Society2006The burden of lung disease [online] Accessed September 20, 2006. URL: http://www.brit-thoracic.org.uk/BurdenofLungDisease2.html.
   Google Scholar
• Altana2005Top line results of first one year study with Daxas [online]. Accessed September 20, 2006. URL: http://www.altana.com/root/index.php?page_id=202&cms_press_id=355
   Google Scholar
• BarnesPJShapiroSDPauwelsRA2003Chronic obstructive pulmonary disease: molecular and cellular mechanismsEur Respir J46728814582923
   PubMed Web of Science ®Google Scholar
• BarnesPJStockleyRA2005COPD: current therapeutic interventions and future approachesEur Respir J6108410615929966
   PubMed Web of Science ®Google Scholar
• BatemanEDHolmesMMuirJF2004Safety profile of roflumilast, a novel, selective phosphodiesterase4 inhibitor, in patients with moderate to severe COPDAm J Respir Crit Care MedA596
   Google Scholar
• BergeronCBouletLP2006Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulationChest410688716608960
   PubMed Web of Science ®Google Scholar
• Boswell-SmithVSpinaDOxfordAW2006The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl) -3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]i soquinolin-4-one]J Pharmacol Exp Ther2840816682455
   PubMed Web of Science ®Google Scholar
• Boszormenyi-NagyGPietersWRSteffenH2005The effect of roflumilast treatment and subsequent withdrawal in patients with COPDProc Am Thorac SocA544
   Google Scholar
• BundschuhDSEltzeMBarsigJ2001In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitorJ Pharmacol Exp Ther12809011259555
   PubMed Web of Science ®Google Scholar
• CherryJADavisRL1999Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement and affectJ Comp Neurol40728730110213096
   PubMed Web of Science ®Google Scholar
• ChurgAWangRDTaiH2004Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouseAm J Respir Crit Care Med5492815184206
   PubMed Web of Science ®Google Scholar
• ChurgAZayKShayS2002Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in miceAm J Respir Cell Mol Biol33687412204900
   PubMed Web of Science ®Google Scholar
• DavidMEZechKSeiberlingA2004Roflumilast, a novel, oral, selective PDE4 inhibitor, shows high absolute bioavalabilityJ Allergy Clin Immunol2780
   Google Scholar
• DentGWhiteSRTenorH1998Cyclic nucleotide phosphodiesterase in human bronchial epithelial cells: characterization of isoenzymes and functional effects of PDE inhibitorsPulm Pharmacol Ther147569802963
   PubMed Web of Science ®Google Scholar
• DerianCKSantulliRJRaoPE1995Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulatorsJ Immunol1308177995950
   PubMed Web of Science ®Google Scholar
• EllisJLUndemBJ1994Role of cysteinyl-leukotrienes and histamine in mediating intrinsic tone in isolated human bronchiAm J Respir Crit Care Med1118228111568
   PubMed Web of Science ®Google Scholar
• EngelstatterRWingertzahnMSchmid-WirlitschC2005Roflumilast, an oral, once-daily phosphodiesterase 4 (PDE4) inhibitor, does not exhibit bronchodilatory activityAnn Allergy Asthma Immunol1159
   Google Scholar
• EssayanDM2001Cyclic nucleotide phosphodiesterasesJ Allergy Clin Immunol56718011692087
   PubMed Web of Science ®Google Scholar
• FuhrmannMJahnHUSeyboldJ1999Identification and function of cyclic nucleotide phosphodiesterase isoenzymes in airway epithelial cellsAm J Respir Cell Mol Biol22923029922221
   PubMed Web of Science ®Google Scholar
• GambleEGrootendorstDCBrightlingCE2003Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med89768212816740
   PubMed Web of Science ®Google Scholar
• GiembyczMA2006An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary diseaseBr J Clin Pharmacol21385216842388
   PubMed Web of Science ®Google Scholar
• GrootendorstDCGauwSASterkPJ2005Treatment with PDE4 Inhibitor Roflumilast Reduces Sputum Neutrophil and Eosinophil Numbers in Patients with COPDProc Am Thorac SocA543
   Google Scholar
• HatzelmannASchudtC2001Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitroJ Pharmacol Exp Ther12677911259554
   PubMed Web of Science ®Google Scholar
• HaunsB2003Investigation of pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects after a single morning or evening oral administration of 500æg roflumilast in healthy subjects-an open, randomised, two-period crossover studyAm J Respir Crit Care Med7A92
   Google Scholar
• HoggJC2004Pathophysiology of airflow limitation in chronic obstructive pulmonary diseaseLancet94357092115325838
   PubMed Web of Science ®Google Scholar
• HouslayMD2001PDE4 cAMP-specific phosphodiesterasesProg Nucleic Acid Res Mol Biol24931511550796
   PubMed Web of Science ®Google Scholar
• HunnemeyerA2002aNo interaction of roflumilast and its active metabolite, roflumilast N-oxide, with inhaled budesonideAm J Respir Crit Care Med8
   Google Scholar
• HunnemeyerAHaunsBDrollmanA2002bPharmacokinetics of roflumilast and its active metabolite roflumilast N-oxide is not influenced by smokingAm J Respir Crit Care Med8A594
   Google Scholar
• ItoKItoMElliottWM2005Decreased histone deacetylase activity in chronic obstructive pulmonary diseaseN Engl J Med1919677615888697
   PubMed Web of Science ®Google Scholar
• JinSLContiM2002Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responsesProc Natl Acad Sci U S A1176283312032334
   PubMed Web of Science ®Google Scholar
• JonesNABoswell-SmithVLeverR2005The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitroPulm Pharmacol Ther29310115649851
   PubMed Web of Science ®Google Scholar
• KeatingsVMCollinsPDScottDM1996Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthmaAm J Respir Crit Care Med253048564092
   PubMed Web of Science ®Google Scholar
• KohyamaTLiuXZhuYK2002Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-alpha and neutrophil elastaseAm J Respir Cell Mol Biol44879412356583
   PubMed Web of Science ®Google Scholar
• KumarRKHerbertCThomasPS2003Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthmaJ Pharmacol Exp Ther13495512954795
   PubMed Web of Science ®Google Scholar
• KwakHJSongJSHeoJY2005Roflumilast inhibits lipo-polysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activationJ Pharmacol Exp Ther311889516126838
   PubMed Web of Science ®Google Scholar
• LamontagneSMeadowsELukP2001Localization of phosphodi-esterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkeyBrain Res128496
   Google Scholar
• LandellsLJSzilagyCMJonesNA2001Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjectsBr J Pharmacol5722911429397
   PubMed Web of Science ®Google Scholar
• LeclercOLagenteVPlanquoisJM2006Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in miceEur Respir J61102916510458
   PubMed Web of Science ®Google Scholar
• LeichtlS2002aEfficacy of once-daily roflumilast, a new, orally active selective phosphodiesterase 4 inhibitor, in chronic obstructive pulmonary diseaseAm J Respir Crit Care MedA229
   Google Scholar
• LeichtlS2002bRoflumilast, a new, orally active, selective phosphodiesterase 4 inhibitor, is safe and well tolerated in patients with Chronic Obstructive Pulmonary DiseaseEur Respir JSuppl38P303s
   Google Scholar
• LenfantCKhaltaevN2005Workshop report: Global strategy for the diagnosis, management, and prevention of COPD [online]Accessed September 20, 2006. URL: http://www.goldcopd.org/Guidelineitem.asp?l1=2&l2=1&intId=989
   Google Scholar
• LipworthBJ2005Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary diseaseLancet94541677515639300
   PubMed Web of Science ®Google Scholar
• LoscoPEEvansEWBaratSA2004The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor, in Cynomolgus monkeysToxicol Pathol329530815204971
   PubMed Web of Science ®Google Scholar
• Martin-ChoulyCAAstierAJacobC2004Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitorsLife Sci78234015183075
   PubMed Web of Science ®Google Scholar
• MartoranaPABeumeRLucattelliM2005Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smokeAm J Respir Crit Care Med78485315961691
   PubMed Web of Science ®Google Scholar
• MataMSarriaBBuenestadoA2005Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cellsThorax21445215681504
   PubMed Web of Science ®Google Scholar
• PauwelsRABuistASCalverleyPM2005Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summaryAm J Respir Crit Care Med5125676
   Google Scholar
• Perez-TorresSMiroXPalaciosJM2000Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brainJ Chem Neuroanat3–434974
   Google Scholar
• ProfitaMChiapparaGMirabellaF2003Effect of cilomilast (Ariflo) on TNF-alpha, IL-8 and GM-CSF release from airway cells of patients with COPDThorax7573912832668
   PubMed Web of Science ®Google Scholar
• RabeKFBatemanEDO’DonnellD2005Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trialLancet94855637116099292
   PubMed Web of Science ®Google Scholar
• RennardSISchachterNStrekM2006Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4Chest1566616424413
   PubMed Web of Science ®Google Scholar
• RetamalesIElliottWMMeshiB2001Amplification of inflammation in emphysema and its association with latent adenoviral infectionAm J Respir Crit Care Med34697311500352
   PubMed Web of Science ®Google Scholar
• SanzMJCortijoJMorcilloEJ2005PDE4 inhibitors as new anti-inflammatory drugs: Effects on cell trafficking and cell adhesion molecules expressionPharmacol Ther32699715922015
   PubMed Web of Science ®Google Scholar
• SchmidtDTWatsonNDentG2000The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airwaysBr J Pharmacol816071811139438
   PubMed Web of Science ®Google Scholar
• ShapiroSD2001End-stage chronic obstructive pulmonary disease: the cigarette is burned out but inflammation rages onAm J Respir Crit Care Med33394011500330
   PubMed Web of Science ®Google Scholar
• ShapiroSDGoldsteinNMHoughtonAM2003Neutrophil elastase contributes to cigarette smoke-induced emphysema in miceAm J Pathol623293514633606
   PubMed Web of Science ®Google Scholar
• SmithSJCieslinskiLBNewtonR2004Discovery of BRL 50481, a Selective Inhibitor of Phosphodiesterase 7: In vitro Studies in Human Monocytes, Lung Macrophages and CD8+ T-LymphocytesMol Pharmacol6616798915371556
   PubMed Web of Science ®Google Scholar
• SpinaD2004The potential of PDE4 inhibitors in respiratory diseaseCurr Drug Targets Inflamm Allergy3231615379590
   PubMedGoogle Scholar
• SpondJChapmanRFineJ2001Comparison of PDE 4 inhibitors, rolipram and SB 207499 (ariflo), in a rat model of pulmonary neutrophiliaPulm Pharmacol Ther21576411273798
   PubMed Web of Science ®Google Scholar
• StollerJKAboussouanLS2005Alpha1-antitrypsin deficiencyLancet947822253615978931
   PubMed Web of Science ®Google Scholar
• SturtonGFitzgeraldM2002Phosphodiesterase 4 inhibitors for the treatment of COPDChest5Suppl192S6S12010850
   PubMed Web of Science ®Google Scholar
• TakahashiMTerwilligerRLaneC1999Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoformsJ Neurosci261089880581
   PubMed Web of Science ®Google Scholar
• Van SchalkwykEStrydomKWilliamsZ2005Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactionsJ Allergy Clin Immunol2292816083782
   PubMed Web of Science ®Google Scholar
• WeimarCBethkeTWestphalK2002Roflumilast and its active metabolite, roflumilast N-oxide, do not interact with inhaled salbutamolAm J Respir Crit Care Med8A594
   Google Scholar